Tower Research Capital LLC (Trc) Xencor Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Xencor Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,383 shares of XNCR stock, worth $80,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,383

Previous 13,327 74.62%

Holding current value

$80,481

Previous $252,000 73.02%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $156,120 - $215,287	-9,944 Reduced 74.62%	3,383 $68,000
Q2 2024 Aug 13, 2024	BUY	$18.21 - $24.5 $239,825 - $322,665	13,170 Added 8388.54%	13,327 $252,000
Q1 2024 May 15, 2024	SELL	$18.65 - $26.52 $315,931 - $449,248	-16,940 Reduced 99.08%	157 $3,000
Q4 2023 Feb 13, 2024	BUY	$16.53 - $21.42 $207,484 - $268,863	12,552 Added 276.17%	17,097 $362,000
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $5,281 - $6,677	263 Added 6.14%	4,545 $91,000
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $45,675 - $55,135	1,844 Added 75.64%	4,282 $106,000
Q1 2023 May 09, 2023	BUY	$25.95 - $36.95 $20,630 - $29,375	795 Added 48.39%	2,438 $68,000
Q4 2022 Feb 10, 2023	SELL	$24.79 - $30.86 $224,002 - $278,850	-9,036 Reduced 84.61%	1,643 $43,000
Q3 2022 Nov 10, 2022	SELL	$24.62 - $32.44 $69,231 - $91,221	-2,812 Reduced 20.84%	10,679 $278,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $247,046 - $363,060	12,515 Added 1282.27%	13,491 $370,000
Q1 2022 May 12, 2022	SELL	$26.68 - $41.63 $231,022 - $360,474	-8,659 Reduced 89.87%	976 $26,000
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $114,646 - $147,913	3,405 Added 54.65%	9,635 $387,000
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $82,877 - $96,478	2,704 Added 76.69%	6,230 $203,000
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $14,040 - $18,274	-409 Reduced 10.39%	3,526 $122,000
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $41,585 - $54,903	1,019 Added 34.95%	3,935 $170,000
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $50,988 - $66,300	1,392 Added 91.34%	2,916 $127,000
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $184,271 - $263,454	-6,124 Reduced 80.07%	1,524 $59,000
Q2 2020 Aug 13, 2020	BUY	$27.76 - $33.42 $212,308 - $255,596	7,648 New	7,648 $248,000
Q4 2019 Feb 07, 2020	SELL	$32.75 - $41.43 $2,849 - $3,604	-87 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$33.73 - $46.27 $3,271 - $4,488	-97 Reduced 52.72%	87 $3,000
Q2 2019 Aug 13, 2019	BUY	$29.6 - $40.93 $5,446 - $7,531	184 New	184 $8,000
Q4 2018 Feb 14, 2019	SELL	$32.39 - $42.05 $117,931 - $153,104	-3,641 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$35.69 - $47.65 $129,947 - $173,493	3,641 New	3,641 $142,000
Q1 2018 May 15, 2018	SELL	$21.18 - $33.78 $10,039 - $16,011	-474 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$19.29 - $24.83 $108,911 - $140,190	-5,646 Reduced 92.25%	474 $10,000
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $120,013 - $142,902	6,120	6,120 $140,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.42B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Xencor Inc Transaction History